PRNewswire08.03.20
Sotera Health has acquired Canadian-based Iotron Industries, an outsourced provider of EBeam sterilization in North America. The acquisition expands Sotera’s electron beam (EBeam) footprint and adds new expertise to its Sterigenics business.
With facilities in Columbia City (Indiana), Port Coquitlam (British Columbia), and Edmonton (Alberta), Iotron Industries has a reputation for customer service, technical expertise and quality performance. Iotron is regarded for its proprietary Impela accelerators, which provide high powered EBeam processing for the sterilization of medical devices and a wide range of industrial applications.
The addition of Iotron will complement Sotera Health's Sterigenics business and enhance Sterigenics' existing global, technology-agnostic sterilization platform.
"While this acquisition expands our overall sterilization footprint, it also enhances our EBeam capabilities and the strength of our offering to the market. We welcome Iotron's management and strong team as they join our mission of safeguarding global health,” said Michael B. Petras Jr., CEO of Sotera Health.
"I am exceedingly proud of the thriving business and expert team that we have built together at Iotron, and we all look forward to accelerating our growth as part of a global leader," added Tino Pereira, president and CEO of Iotron Industries. "Iotron and Sotera Health share common values around safety, customer focus, integrity, people, and a commitment to excellence. We look forward to a brighter future together."
With facilities in Columbia City (Indiana), Port Coquitlam (British Columbia), and Edmonton (Alberta), Iotron Industries has a reputation for customer service, technical expertise and quality performance. Iotron is regarded for its proprietary Impela accelerators, which provide high powered EBeam processing for the sterilization of medical devices and a wide range of industrial applications.
The addition of Iotron will complement Sotera Health's Sterigenics business and enhance Sterigenics' existing global, technology-agnostic sterilization platform.
"While this acquisition expands our overall sterilization footprint, it also enhances our EBeam capabilities and the strength of our offering to the market. We welcome Iotron's management and strong team as they join our mission of safeguarding global health,” said Michael B. Petras Jr., CEO of Sotera Health.
"I am exceedingly proud of the thriving business and expert team that we have built together at Iotron, and we all look forward to accelerating our growth as part of a global leader," added Tino Pereira, president and CEO of Iotron Industries. "Iotron and Sotera Health share common values around safety, customer focus, integrity, people, and a commitment to excellence. We look forward to a brighter future together."
